Novavax NVAX Europe — Revenue from Contract with Customer, Excluding Assessed Tax
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's europe — revenue from contract with customer, excluding assessed tax.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's europe — revenue from contract with customer, excluding assessed tax?
- Novavax (NVAX) reported europe — revenue from contract with customer, excluding assessed tax of $20.15M in Q1 2026.
- How has Novavax's europe — revenue from contract with customer, excluding assessed tax changed year-over-year?
- Novavax's europe — revenue from contract with customer, excluding assessed tax increased by 149.1% year-over-year, from $8.09M to $20.15M.
- What is the long-term trend for Novavax's europe — revenue from contract with customer, excluding assessed tax?
- Over 3 years (2022 to 2025), Novavax's europe — revenue from contract with customer, excluding assessed tax has grown at a -73.3% compound annual growth rate (CAGR), from $826.83M to $15.74M.
- What does europe — revenue from contract with customer, excluding assessed tax mean?
- This metric represents the total revenue recognized from contracts with customers within the European geographic segment, excluding any assessed taxes such as sales or value-added taxes. It serves as a primary indicator of the company's commercial performance and market penetration within the European region. Monitoring this figure helps investors assess the demand for the company's products and the effectiveness of its regional sales strategy.